Shah VP - Search Results

1

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levetiracetam.

Petruševska M, Berglez S, Krisch I, Legen I, Megušar K, Peternel L, Abrahamsson B, Cristofoletti R, Groot DW, Kopp S, Langguth P, Mehta M, Polli JE, Shah VP, Dressman J. Petruševska M, et al. Among authors: shah vp. J Pharm Sci. 2015 Sep;104(9):2676-87. doi: 10.1002/jps.24350. Epub 2015 Feb 6. J Pharm Sci. 2015. PMID: 25663270 Review.

2

Principles and criteria in the development and optimization of topical therapeutic products.

Shah VP, Behl CR, Flynn GL, Higuchi WI, Schaefer H. Shah VP, et al. Pharm Res. 1992 Aug;9(8):1107-11. doi: 10.1023/a:1015831201020. Pharm Res. 1992. PMID: 1357648 Free article. No abstract available.

3

Principles and criteria in the development and optimization of topical therapeutic products.

Shah VP, Behl CR, Flynn GL, Higuchi WI, Schaefer H. Shah VP, et al. J Pharm Sci. 1992 Oct;81(10):1051-4. doi: 10.1002/jps.2600811020. J Pharm Sci. 1992. PMID: 1432620 Review. No abstract available.

4

The bioinequivalence of carbamazepine tablets with a history of clinical failures.

Meyer MC, Straughn AB, Jarvi EJ, Wood GC, Pelsor FR, Shah VP. Meyer MC, et al. Among authors: shah vp. Pharm Res. 1992 Dec;9(12):1612-6. doi: 10.1023/a:1015872626887. Pharm Res. 1992. PMID: 1488405

5

Influence of higher rates of agitation on release patterns of immediate-release drug products.

Shah VP, Gurbarg M, Noory A, Dighe S, Skelly JP. Shah VP, et al. J Pharm Sci. 1992 Jun;81(6):500-3. doi: 10.1002/jps.2600810604. J Pharm Sci. 1992. PMID: 1522485

6

Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams.

Shah VP, Elkins J, Skelly JP. Shah VP, et al. J Pharm Sci. 1992 Jan;81(1):104-6. doi: 10.1002/jps.2600810121. J Pharm Sci. 1992. PMID: 1619561

7

In vivo percutaneous penetration/absorption, Washington, D.C., May 1989.

Shah VP, Flynn GL, Guy RH, Maibach HI, Schaefer H, Skelly JP, Wester RC, Yacobi A. Shah VP, et al. Pharm Res. 1991 Aug;8(8):1071-5. doi: 10.1023/a:1015829729439. Pharm Res. 1991. PMID: 1924164 Free article. No abstract available.

8

Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms.

Skelley JP, Amidon GL, Barr WH, Benet LZ, Carter JE, Robinson JR, Shah VP, Yacobi A. Skelley JP, et al. Among authors: shah vp. J Pharm Sci. 1990 Sep;79(9):849-54. doi: 10.1002/jps.2600790923. J Pharm Sci. 1990. PMID: 1980308 No abstract available.

9

In vitro release profiles of clonidine transdermal therapeutic systems and scopolamine transdermal patches.

Shah VP, Tymes NW, Skelly JP. Shah VP, et al. Pharm Res. 1989 Apr;6(4):346-51. doi: 10.1023/a:1015962911344. Pharm Res. 1989. PMID: 2748524 No abstract available.

10

Analysis of in vitro dissolution of whole vs. half controlled-release theophylline tablets.

Shah VP, Yamamoto LA, Schuirman D, Elkins J, Skelly JP. Shah VP, et al. Pharm Res. 1987 Oct;4(5):416-9. doi: 10.1023/a:1016442514205. Pharm Res. 1987. PMID: 3508552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters